StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) stock

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

AnaptysBio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

AnaptysBio's price to sales ratio was 6.2× on Oct 19, 2026, against 5.5× a year earlier. Over the last 5 years it ranged from 3.1× to 130.5×, with a median of 8.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20266.2×+0.9
2025Dec 31, 20255.3×+0.6
2024Dec 31, 20244.7×−20.7
2023Dec 29, 202325.4×−105.1
2022Dec 30, 2022130.5×+125.3
2021Dec 31, 20215.2×−16.6
2020Dec 31, 202021.8×−36.9
2019Dec 31, 201958.7×−83.5
2018Dec 31, 2018142.2×+1.1
2017Dec 29, 2017141.1×–

More AnaptysBio figures

See a number that looks wrong?